Support Dr. Frazier's Research's Fundraising Page

Gifts made through this page will directly support Dr. Lindsay Frazier’s most pressing cancer research and care priorities including adolescent and young adult oncology, oncofertility, and germ cell tumors.

The Center for Adolescent and Young Adult Oncology (CAYAO)
The cancers common in adolescent and young adult (AYA) cancer patients are a distinct set of tumors, that are neither the cancers of children nor adults. As a result, medical care is required from physicians with specialized knowledge. Dana-Farber has some of the leading experts in AYA cancers in the United States. What is unique about the care offered at DFCI is that through the Center, patients have access to that expertise from the faculty of both pediatric and medical oncology, who are co-located at the Institute.  Teenage and young adult patient face other significant challenged: they often feel isolated from their peers, and need guidance on the ways in which cancer can disrupt their lives, change their relationships, and affect their plans for college and career. Co-Led by Dr. Frazier from pediatric oncology and Dr. Ann LaCasce from medical oncology, CAYAO aims to provide the best possible care to AYA patients by providing tailored medical input, and AYA-specific supportive care services, including a designated AYA waiting room, and information about AYA research and trials. Philanthropy is critical to growing the CAYAO.

Oncofertility
Thanks to remarkable research and treatment advances, many of which were pioneered at Dana-Farber, more than 80 percent of children diagnosed with cancer will survive. As treatments for childhood cancers have improved, more childhood cancer patients can anticipate starting families of their own. Dana-Farber’s Pediatric Fertility Preservation Program, led by Dr. Frazier, provides consultations to every new patient-family to share information on known fertility risks that accompany treatments. Dr. Frazier would like to utilize philanthropy to establish a patient assistance fund, which would cover the cost of fertility preservation and storage for those who do not have the requisite insurance coverage.

Germ Cell Tumors & the Malignant Germ Cell International Consortium
Dr. Frazier has led the formation of Malignant Germ Cell International Consortium (MaGIC), an international group of germ cell tumor (GCT) specialists.  The collaboration brings together a wide range of disciplines—clinical trialists, basic scientists, bioinformaticists, pathologists, statisticians, surgeons, epidemiologists, and patient advocates.  Since its inception in 2009, MaGIC has grown to include over 100 individuals from more than 50 institutions in 14 countries. Sharing expertise, perspective, and culture continues to create new opportunities for advancement in the field of GCT research.  MaGIC currently has 3 international NCI-funded clinical trials underway, is planning the next generation of trials, sponsoring basic and translational research, and training next generation of young investigators worldwide. The MaGIC Data Commons, which integrates clinical, biologic and genomic data, serves as the backbone of MaGIC research.  Philanthropy will help accelerate MaGIC research and the translation of discoveries into improved patient outcomes. To learn more, please visit https://magicconsortium.com

Thank you for considering a gift to these important initiatives. To make a gift via check, please write "Dr. Frazier’s Giving Page" in memo line and send to:

Dana-Farber Cancer Institute
Division of Philanthropy & The Jimmy Fund
Attn: Kelsey Cunningham
10 Brookline Place West, 6th Floor
Brookline, MA 02445
857-215-0297